Susquehanna Portfolio Strategies »

Myriad Genetics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Myriad Genetics (MYGN) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Myriad Genetics

Tip: Access up to 7 years of quarterly data

All positions including Myriad Genetics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Myriad Genetics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.8M 384k 7.23
2025-06-30 $2.4M 456k 5.31

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Myriad Genetics

BlackRock
Vanguard Group
State Street Corporation
Millennium Management
Glenview Captal Management
D. E. Shaw & Co
Morgan Stanley
Jacobs Levy Equity Management
Geode Capital Management
Goldman Sachs Group
Camber Capital Management
Dimensional Fund Advisors
Charles Schwab Investment Management
AQR Capital Management
Assenagon Asset Management

View all funds holding Myriad Genetics